Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche

Onju Ham, Se Yeon Lee, Byeong Wook Song, Min Ji Cha, Chang Youn Lee, Jun Hee Park, Il Kwon Kim, Jiyun Lee, Hyang Hee Seo, Min Ji Seung, Eunhyun Choi, Yangsoo Jang, Ki Chul Hwang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) have the potential to repair and regenerate ischemic heart tissue; however, the poor viability of transplanted MSCs in the ischemic region is a major obstacle to their therapeutic use. This cell death is caused by Fas and Fas ligand (FasL) interactions under harsh conditions. To investigate improving the survival and therapeutic effects of MSCs, we focused our research on Fas–FasL-mediated cell death. In this study, we found that the poor viability of transplanted MSCs was caused by Fas–FasL interactions between host ischemic myocardial cells and implanted MSCs. In addition, we found that increased Fas expression and the corresponding decrease of cell survival were in close relation to hypoxic MSCs treated with FasL and H2O2. When MSCs were treated with a recombinant Fas/Fc chimera (Fas/Fc) inhibiting Fas–FasL interactions, the expressions of proapoptotic proteins including caspase-8, caspase-3, Bax, and cytochrome-c were attenuated, and the survival of MSCs was recovered. In ischemia–reperfusion injury models, the interaction between FasL in ischemic heart and Fas in implanted MSCs caused a loss of transplanted MSCs, whereas the inhibition of this interaction by Fas/Fc treatment improved cell survival and restored heart function. Thus, our study suggests that Fas–FasL interactions are responsible for activating cell death signaling in implanted stem cells and could be a potential target for improving therapeutic efficacy of stem cells in treating ischemic heart diseases.

Original languageEnglish
Pages (from-to)1329-1341
Number of pages13
JournalCell transplantation
Volume24
Issue number7
DOIs
Publication statusPublished - 2015 Jul 15

Fingerprint

Cell death
Stem cells
Mesenchymal Stromal Cells
Myocardium
Ligands
Modulation
Apoptosis
Fas Ligand Protein
Cell Death
Therapeutic Uses
Cell Survival
Stem Cells
Hypoxia
Cells
Caspase 8
Proteins
Cytochromes c
Caspase 3
Myocardial Ischemia
Repair

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Ham, Onju ; Lee, Se Yeon ; Song, Byeong Wook ; Cha, Min Ji ; Lee, Chang Youn ; Park, Jun Hee ; Kim, Il Kwon ; Lee, Jiyun ; Seo, Hyang Hee ; Seung, Min Ji ; Choi, Eunhyun ; Jang, Yangsoo ; Hwang, Ki Chul. / Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche. In: Cell transplantation. 2015 ; Vol. 24, No. 7. pp. 1329-1341.
@article{cef0e6a75cb14447b08751bf6fccb31d,
title = "Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche",
abstract = "Mesenchymal stem cells (MSCs) have the potential to repair and regenerate ischemic heart tissue; however, the poor viability of transplanted MSCs in the ischemic region is a major obstacle to their therapeutic use. This cell death is caused by Fas and Fas ligand (FasL) interactions under harsh conditions. To investigate improving the survival and therapeutic effects of MSCs, we focused our research on Fas–FasL-mediated cell death. In this study, we found that the poor viability of transplanted MSCs was caused by Fas–FasL interactions between host ischemic myocardial cells and implanted MSCs. In addition, we found that increased Fas expression and the corresponding decrease of cell survival were in close relation to hypoxic MSCs treated with FasL and H2O2. When MSCs were treated with a recombinant Fas/Fc chimera (Fas/Fc) inhibiting Fas–FasL interactions, the expressions of proapoptotic proteins including caspase-8, caspase-3, Bax, and cytochrome-c were attenuated, and the survival of MSCs was recovered. In ischemia–reperfusion injury models, the interaction between FasL in ischemic heart and Fas in implanted MSCs caused a loss of transplanted MSCs, whereas the inhibition of this interaction by Fas/Fc treatment improved cell survival and restored heart function. Thus, our study suggests that Fas–FasL interactions are responsible for activating cell death signaling in implanted stem cells and could be a potential target for improving therapeutic efficacy of stem cells in treating ischemic heart diseases.",
author = "Onju Ham and Lee, {Se Yeon} and Song, {Byeong Wook} and Cha, {Min Ji} and Lee, {Chang Youn} and Park, {Jun Hee} and Kim, {Il Kwon} and Jiyun Lee and Seo, {Hyang Hee} and Seung, {Min Ji} and Eunhyun Choi and Yangsoo Jang and Hwang, {Ki Chul}",
year = "2015",
month = "7",
day = "15",
doi = "10.3727/096368914X681748",
language = "English",
volume = "24",
pages = "1329--1341",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "7",

}

Ham, O, Lee, SY, Song, BW, Cha, MJ, Lee, CY, Park, JH, Kim, IK, Lee, J, Seo, HH, Seung, MJ, Choi, E, Jang, Y & Hwang, KC 2015, 'Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche', Cell transplantation, vol. 24, no. 7, pp. 1329-1341. https://doi.org/10.3727/096368914X681748

Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche. / Ham, Onju; Lee, Se Yeon; Song, Byeong Wook; Cha, Min Ji; Lee, Chang Youn; Park, Jun Hee; Kim, Il Kwon; Lee, Jiyun; Seo, Hyang Hee; Seung, Min Ji; Choi, Eunhyun; Jang, Yangsoo; Hwang, Ki Chul.

In: Cell transplantation, Vol. 24, No. 7, 15.07.2015, p. 1329-1341.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of Fas–Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche

AU - Ham, Onju

AU - Lee, Se Yeon

AU - Song, Byeong Wook

AU - Cha, Min Ji

AU - Lee, Chang Youn

AU - Park, Jun Hee

AU - Kim, Il Kwon

AU - Lee, Jiyun

AU - Seo, Hyang Hee

AU - Seung, Min Ji

AU - Choi, Eunhyun

AU - Jang, Yangsoo

AU - Hwang, Ki Chul

PY - 2015/7/15

Y1 - 2015/7/15

N2 - Mesenchymal stem cells (MSCs) have the potential to repair and regenerate ischemic heart tissue; however, the poor viability of transplanted MSCs in the ischemic region is a major obstacle to their therapeutic use. This cell death is caused by Fas and Fas ligand (FasL) interactions under harsh conditions. To investigate improving the survival and therapeutic effects of MSCs, we focused our research on Fas–FasL-mediated cell death. In this study, we found that the poor viability of transplanted MSCs was caused by Fas–FasL interactions between host ischemic myocardial cells and implanted MSCs. In addition, we found that increased Fas expression and the corresponding decrease of cell survival were in close relation to hypoxic MSCs treated with FasL and H2O2. When MSCs were treated with a recombinant Fas/Fc chimera (Fas/Fc) inhibiting Fas–FasL interactions, the expressions of proapoptotic proteins including caspase-8, caspase-3, Bax, and cytochrome-c were attenuated, and the survival of MSCs was recovered. In ischemia–reperfusion injury models, the interaction between FasL in ischemic heart and Fas in implanted MSCs caused a loss of transplanted MSCs, whereas the inhibition of this interaction by Fas/Fc treatment improved cell survival and restored heart function. Thus, our study suggests that Fas–FasL interactions are responsible for activating cell death signaling in implanted stem cells and could be a potential target for improving therapeutic efficacy of stem cells in treating ischemic heart diseases.

AB - Mesenchymal stem cells (MSCs) have the potential to repair and regenerate ischemic heart tissue; however, the poor viability of transplanted MSCs in the ischemic region is a major obstacle to their therapeutic use. This cell death is caused by Fas and Fas ligand (FasL) interactions under harsh conditions. To investigate improving the survival and therapeutic effects of MSCs, we focused our research on Fas–FasL-mediated cell death. In this study, we found that the poor viability of transplanted MSCs was caused by Fas–FasL interactions between host ischemic myocardial cells and implanted MSCs. In addition, we found that increased Fas expression and the corresponding decrease of cell survival were in close relation to hypoxic MSCs treated with FasL and H2O2. When MSCs were treated with a recombinant Fas/Fc chimera (Fas/Fc) inhibiting Fas–FasL interactions, the expressions of proapoptotic proteins including caspase-8, caspase-3, Bax, and cytochrome-c were attenuated, and the survival of MSCs was recovered. In ischemia–reperfusion injury models, the interaction between FasL in ischemic heart and Fas in implanted MSCs caused a loss of transplanted MSCs, whereas the inhibition of this interaction by Fas/Fc treatment improved cell survival and restored heart function. Thus, our study suggests that Fas–FasL interactions are responsible for activating cell death signaling in implanted stem cells and could be a potential target for improving therapeutic efficacy of stem cells in treating ischemic heart diseases.

UR - http://www.scopus.com/inward/record.url?scp=84937392492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937392492&partnerID=8YFLogxK

U2 - 10.3727/096368914X681748

DO - 10.3727/096368914X681748

M3 - Article

C2 - 24823387

AN - SCOPUS:84937392492

VL - 24

SP - 1329

EP - 1341

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 7

ER -